FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004709207> ?p ?o ?g. }

• W2004709207 endingPage "760.e2" @default.
• W2004709207 startingPage "751" @default.
• W2004709207 abstract "Background & AimsIndividuals with human immunodeficiency virus (HIV) infection frequently also are infected with hepatitis C virus (HCV) (co-infection), but little is known about its effects on the progression of HIV-associated disease. We aimed to determine the effects of co-infection on mortality from HIV and/or acquired immune deficiency syndrome (AIDS), and hepatitis or liver disease, adjusting for the duration of HIV infection.MethodsWe analyzed data from the 16 cohorts of the Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) collaboration, which included information on HCV infection and cause of death. A competing-risks proportional subdistribution hazards model was used to evaluate the effect of HCV infection on the following causes of death: HIV- and/or AIDS-related, hepatitis- or liver-related, natural, and non-natural.ResultsOf 9164 individuals with HIV infection and a known date of seroconversion, 2015 (22.0%) also were infected with HCV. Of 718 deaths, 395 (55.0%) were caused by HIV infection and/or AIDS, and 39 (5.4%) were caused by hepatitis or liver-related disease. Among individuals infected with only HIV or with co-infection, the mortality from HIV infection and/or AIDS-related causes and hepatitis or liver disease decreased significantly after 1997, when combination antiretroviral therapy became widely available. However, after 1997, HIV and/or AIDS-related mortality was higher among co-infected individuals than those with only HIV infection in each risk group: injection drug use (adjusted hazard ratio [aHR], 2.43; 95% confidence interval [CI], 1.14–5.20), sex between men and women or hemophilia (aHR, 3.43; 95% CI, 1.70–6.93), and sex between men (aHR, 3.11; 95% CI, 1.49–6.48). Compared with individuals infected with only HIV, co-infected individuals had a higher risk of death from hepatitis or liver disease.ConclusionsBased on analysis of data from the CASCADE collaboration, since 1997, when combination antiretroviral therapy became widely available, individuals co-infected with HIV and HCV have had a higher risk of death from HIV and/or AIDS, and from hepatitis or liver disease, than patients infected with only HIV. It is necessary to evaluate the effects of HCV therapy on HIV progression. Individuals with human immunodeficiency virus (HIV) infection frequently also are infected with hepatitis C virus (HCV) (co-infection), but little is known about its effects on the progression of HIV-associated disease. We aimed to determine the effects of co-infection on mortality from HIV and/or acquired immune deficiency syndrome (AIDS), and hepatitis or liver disease, adjusting for the duration of HIV infection. We analyzed data from the 16 cohorts of the Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) collaboration, which included information on HCV infection and cause of death. A competing-risks proportional subdistribution hazards model was used to evaluate the effect of HCV infection on the following causes of death: HIV- and/or AIDS-related, hepatitis- or liver-related, natural, and non-natural. Of 9164 individuals with HIV infection and a known date of seroconversion, 2015 (22.0%) also were infected with HCV. Of 718 deaths, 395 (55.0%) were caused by HIV infection and/or AIDS, and 39 (5.4%) were caused by hepatitis or liver-related disease. Among individuals infected with only HIV or with co-infection, the mortality from HIV infection and/or AIDS-related causes and hepatitis or liver disease decreased significantly after 1997, when combination antiretroviral therapy became widely available. However, after 1997, HIV and/or AIDS-related mortality was higher among co-infected individuals than those with only HIV infection in each risk group: injection drug use (adjusted hazard ratio [aHR], 2.43; 95% confidence interval [CI], 1.14–5.20), sex between men and women or hemophilia (aHR, 3.43; 95% CI, 1.70–6.93), and sex between men (aHR, 3.11; 95% CI, 1.49–6.48). Compared with individuals infected with only HIV, co-infected individuals had a higher risk of death from hepatitis or liver disease. Based on analysis of data from the CASCADE collaboration, since 1997, when combination antiretroviral therapy became widely available, individuals co-infected with HIV and HCV have had a higher risk of death from HIV and/or AIDS, and from hepatitis or liver disease, than patients infected with only HIV. It is necessary to evaluate the effects of HCV therapy on HIV progression." @default.
• W2004709207 created "2016-06-24" @default.
• W2004709207 creator A5012339925 @default.
• W2004709207 creator A5043675426 @default.
• W2004709207 creator A5045448757 @default.
• W2004709207 creator A5053100916 @default.
• W2004709207 creator A5059232694 @default.
• W2004709207 creator A5069415900 @default.
• W2004709207 creator A5076099897 @default.
• W2004709207 creator A5081460531 @default.
• W2004709207 creator A5081694461 @default.
• W2004709207 creator A5085571849 @default.
• W2004709207 date "2013-04-01" @default.
• W2004709207 modified "2023-10-17" @default.
• W2004709207 title "Effect of HCV Infection on Cause-Specific Mortality After HIV Seroconversion, Before and After 1997" @default.
• W2004709207 cites W1964670754 @default.
• W2004709207 cites W1967377012 @default.
• W2004709207 cites W1990245648 @default.
• W2004709207 cites W1991270979 @default.
• W2004709207 cites W1991653276 @default.
• W2004709207 cites W1992668008 @default.
• W2004709207 cites W1996083965 @default.
• W2004709207 cites W2001634163 @default.
• W2004709207 cites W2011265976 @default.
• W2004709207 cites W2018253571 @default.
• W2004709207 cites W2024703759 @default.
• W2004709207 cites W2035095186 @default.
• W2004709207 cites W2038738704 @default.
• W2004709207 cites W2040351784 @default.
• W2004709207 cites W2045772477 @default.
• W2004709207 cites W2047127491 @default.
• W2004709207 cites W2057847137 @default.
• W2004709207 cites W2062080206 @default.
• W2004709207 cites W2064448796 @default.
• W2004709207 cites W2064583974 @default.
• W2004709207 cites W2068074952 @default.
• W2004709207 cites W2069273544 @default.
• W2004709207 cites W2071403876 @default.
• W2004709207 cites W2074115135 @default.
• W2004709207 cites W2091045718 @default.
• W2004709207 cites W2101368910 @default.
• W2004709207 cites W2108513094 @default.
• W2004709207 cites W2113676816 @default.
• W2004709207 cites W2113864802 @default.
• W2004709207 cites W2120388411 @default.
• W2004709207 cites W2147354200 @default.
• W2004709207 cites W2152664737 @default.
• W2004709207 cites W2156380404 @default.
• W2004709207 cites W2160997908 @default.
• W2004709207 cites W2165374230 @default.
• W2004709207 cites W2309506771 @default.
• W2004709207 cites W2320342518 @default.
• W2004709207 cites W4211077792 @default.
• W2004709207 doi "https://doi.org/10.1053/j.gastro.2012.12.026" @default.
• W2004709207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23266560" @default.
• W2004709207 hasPublicationYear "2013" @default.
• W2004709207 type Work @default.
• W2004709207 sameAs 2004709207 @default.
• W2004709207 citedByCount "72" @default.
• W2004709207 countsByYear W20047092072013 @default.
• W2004709207 countsByYear W20047092072014 @default.
• W2004709207 countsByYear W20047092072015 @default.
• W2004709207 countsByYear W20047092072016 @default.
• W2004709207 countsByYear W20047092072017 @default.
• W2004709207 countsByYear W20047092072018 @default.
• W2004709207 countsByYear W20047092072019 @default.
• W2004709207 countsByYear W20047092072020 @default.
• W2004709207 countsByYear W20047092072021 @default.
• W2004709207 countsByYear W20047092072022 @default.
• W2004709207 crossrefType "journal-article" @default.
• W2004709207 hasAuthorship W2004709207A5012339925 @default.
• W2004709207 hasAuthorship W2004709207A5043675426 @default.
• W2004709207 hasAuthorship W2004709207A5045448757 @default.
• W2004709207 hasAuthorship W2004709207A5053100916 @default.
• W2004709207 hasAuthorship W2004709207A5059232694 @default.
• W2004709207 hasAuthorship W2004709207A5069415900 @default.
• W2004709207 hasAuthorship W2004709207A5076099897 @default.
• W2004709207 hasAuthorship W2004709207A5081460531 @default.
• W2004709207 hasAuthorship W2004709207A5081694461 @default.
• W2004709207 hasAuthorship W2004709207A5085571849 @default.
• W2004709207 hasBestOaLocation W20047092071 @default.
• W2004709207 hasConcept C126322002 @default.
• W2004709207 hasConcept C159047783 @default.
• W2004709207 hasConcept C203014093 @default.
• W2004709207 hasConcept C2522874641 @default.
• W2004709207 hasConcept C2776029263 @default.
• W2004709207 hasConcept C2776408679 @default.
• W2004709207 hasConcept C2776455275 @default.
• W2004709207 hasConcept C2777075537 @default.
• W2004709207 hasConcept C2777451964 @default.
• W2004709207 hasConcept C2777813720 @default.
• W2004709207 hasConcept C2780727368 @default.
• W2004709207 hasConcept C3013748606 @default.
• W2004709207 hasConcept C71924100 @default.
• W2004709207 hasConceptScore W2004709207C126322002 @default.
• W2004709207 hasConceptScore W2004709207C159047783 @default.
• W2004709207 hasConceptScore W2004709207C203014093 @default.
• W2004709207 hasConceptScore W2004709207C2522874641 @default.

• next